SEC Company Response from Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Jan 30, 2017
Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: Jan. 30, 2017 · CIK: 0000748592 · Accession: 0001493152-17-000947
AI Filing Summary & Sentiment
File numbers found in text: 333-215271
Show Raw Text
CORRESP
1
filename1.htm
January
30, 2017
VIA
EDGAR
Mr.
Larry Spirgel, Assistant Director
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F. Street, N.E.
Washington,
D.C. 20549
Re:
NTN
Buzztime, Inc. (the “Company”)
Registration
Statement on Form S-3 (File No. 333-215271)
Mr.
Spirgel:
In
accordance with Rule 461 under the Securities Act of 1933, the undersigned respectfully requests that the effective date for the
registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February
2, 2017, or as soon thereafter as is practicable.
If
you have any questions regarding this request, please contact the Company’s securities counsel, Edwin Astudillo (edwin@breakwaterlawgroup.com;
619.318.9987) or me (sandra.gurrola@buzztime.com; 760.930.1168).
Sincerely,
NTN Buzztime, Inc.
/s/ Sandra Gurrola
Sandra Gurrola
Vice President of Finance
cc:
Courtney
Lindsay, U.S. Securities and Exchange Commission
Edwin
Astudillo, Breakwater Law Group, LLP (via e-mail)